Related Experiment Video
Updated: Dec 29, 2025

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Risk factors for development of diabetes mellitus (Type 3c) after partial pancreatectomy: A systematic review
Linda Wu1, Christopher B Nahm2,3, Nigel B Jamieson2
1Department of Endocrinology, Royal North Shore Hospital, Sydney, NSW, Australia.
Objectives:
Type 3c diabetes mellitus (T3cDM) occurring post pancreatectomy can be challenging to treat due to the frequent combination of decreased circulating levels of insulin and glucagon and concurrent exocrine insufficiency. Relatively, little is known regarding the risk factors for development of T3cDM post pancreatectomy. Our aim was to review the literature and assess what is known of the risk factors for the development of new-onset DM following partial pancreatic resection and where possible determines the incidence, time of onset and the management approach to hyperglycaemia in this context.
Design:
Medline and Embase databases were reviewed using specific keyword criteria. Original manuscripts published in 1990 or later included. Articles with study population <20, lacking information on new-onset DM, follow-up duration or specifically targeting rare procedures/pathology were excluded. The Newcastle Ottawa Quality Assessment form was applied. Results reported according to PRISMA guidelines. Pooled effect size calculated using random effects model.
Patients:
Thirty six articles were identified that described a total of 5636 patients undergoing pancreaticoduodenectomy, 3922 patients having distal pancreatectomy and 315 with central pancreatectomy.
Results:
The incidence of new-onset DM was significantly different between different types of resection from 9% to 24% after pancreaticoduodenectomy (pooled estimate 16%; 95% CI: 14%-17%), 3%-40% after distal pancreatectomy (pooled estimate 21%; 95% CI: 16%-25%) and 0%-14% after central pancreatectomy (pooled estimate 6%; 95% CI: 3%-9%). Surgical site, higher preoperative HbA1c, fasting plasma glucose and lower remnant pancreatic volume had strongest associations with new-onset DM.
Conclusions:
This systematic review supports that risk of development of T3cDM is associated with type of pancreatic resection, lower remnant pancreatic volume and higher preoperative HbA1c.
Insights
Type 3c diabetes mellitus (T3cDM) risk after pancreatic surgery depends on the resection type. Lower remnant pancreatic volume and higher preoperative HbA1c are key risk factors for developing T3cDM.
Area of Science:
- Endocrinology
- Gastroenterology
- Surgical Oncology
Background:
- Type 3c diabetes mellitus (T3cDM) is a complex endocrine disorder following pancreatic surgery.
- It presents unique challenges due to hormonal imbalances and exocrine insufficiency.
- Risk factors for T3cDM post-pancreatectomy remain incompletely understood.
Purpose of the Study:
- To systematically review the literature on risk factors for new-onset diabetes mellitus (DM) after partial pancreatic resection.
- To assess the incidence, onset timing, and hyperglycemia management of T3cDM in this context.
Main Methods:
- A systematic literature review of Medline and Embase databases (1990 onwards).
- Inclusion of original articles with adequate patient numbers and follow-up data.
- Quality assessment using the Newcastle Ottawa Scale and results reported per PRISMA guidelines.
Main Results:
- Analysis of 36 articles involving 5636 pancreaticoduodenectomies, 3922 distal pancreatectomies, and 315 central pancreatectomies.
- Incidence of new-onset DM varied by resection type: 16% (pancreaticoduodenectomy), 21% (distal pancreatectomy), and 6% (central pancreatectomy).
- Strongest associations with new-onset DM included surgical site, higher preoperative HbA1c, fasting plasma glucose, and lower remnant pancreatic volume.
Conclusions:
- The type of pancreatic resection is a significant factor in T3cDM development.
- Lower remnant pancreatic volume and elevated preoperative HbA1c are critical risk factors.
- Further research can refine understanding and management strategies for T3cDM.
More Related Videos
09:33Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
Published on: June 2, 2018
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...